Approval for the bio-rad monolisa anti-hbc igm eia.  The device is indicated for:  the bio-rad monolisa anti-hbc igm eia is an enzyme immunoassay intended for use in the qualitative detection of igm antibodies to hepatitis b core antigen (anti-hbc igm) in human serum or plasma (potassium edta, sodium citrate, acd [acid citrate dextrose], lithium heparin and sodium heparin).  Assay results may be used with other hbv serological markers for the laboratory diagnosis of hbv disease associated with hbv infection.